Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion type Assertion NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_head.
- NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion description "[Recently, several new and specific thymidylate synthase inhibitors that occupy the folate binding site, including Tomudex(R), BW1843U89, and Thymitaq, have demonstrated therapeutic activity in patients with advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion evidence source_evidence_literature NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion SIO_000772 9565579 NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion wasDerivedFrom befree-2016 NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.
- NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_assertion wasGeneratedBy ECO_0000203 NP1394033.RA_kxnMveH2DoKc_Vku715X_oMexwy62Oa_YqcODjUagk130_provenance.